These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28825813)

  • 1. Highly Potent and Selective New Diphenethylamines Interacting with the κ-Opioid Receptor: Synthesis, Pharmacology, and Structure-Activity Relationships.
    Erli F; Guerrieri E; Ben Haddou T; Lantero A; Mairegger M; Schmidhammer H; Spetea M
    J Med Chem; 2017 Sep; 60(17):7579-7590. PubMed ID: 28825813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and pharmacological evaluation of a diphenethylamine derivative (HS665), a highly potent and selective κ opioid receptor agonist.
    Spetea M; Berzetei-Gurske IP; Guerrieri E; Schmidhammer H
    J Med Chem; 2012 Nov; 55(22):10302-6. PubMed ID: 23134120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective κ receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice.
    Spetea M; Eans SO; Ganno ML; Lantero A; Mairegger M; Toll L; Schmidhammer H; McLaughlin JP
    Br J Pharmacol; 2017 Aug; 174(15):2444-2456. PubMed ID: 28494108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural determinants of diphenethylamines for interaction with the κ opioid receptor: Synthesis, pharmacology and molecular modeling studies.
    Guerrieri E; Bermudez M; Wolber G; Berzetei-Gurske IP; Schmidhammer H; Spetea M
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4769-4774. PubMed ID: 27567368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of [(3)H]HS665, a novel, highly selective radioligand for the kappa opioid receptor.
    Guerrieri E; Mallareddy JR; Tóth G; Schmidhammer H; Spetea M
    ACS Chem Neurosci; 2015 Mar; 6(3):456-63. PubMed ID: 25496417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.
    Hiebel AC; Lee YS; Bilsky E; Giuvelis D; Deschamps JR; Parrish DA; Aceto MD; May EL; Harris LS; Coop A; Dersch CM; Partilla JS; Rothman RB; Cheng K; Jacobson AE; Rice KC
    J Med Chem; 2007 Aug; 50(16):3765-76. PubMed ID: 17625813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structurally Related Kappa Opioid Receptor Agonists with Substantial Differential Signaling Bias: Neuroendocrine and Behavioral Effects in C57BL6 Mice.
    Dunn AD; Reed B; Guariglia C; Dunn AM; Hillman JM; Kreek MJ
    Int J Neuropsychopharmacol; 2018 Sep; 21(9):847-857. PubMed ID: 29635340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
    Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
    J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 6,14-epoxymorphinan derivatives and their pharmacologies.
    Nemoto T; Yamamoto N; Watanabe A; Fujii H; Hasebe K; Nakajima M; Mochizuki H; Nagase H
    Bioorg Med Chem; 2011 Feb; 19(3):1205-21. PubMed ID: 21256034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of substitution on the pyrrole N atom in derivatives of tetrahydronaltrindole, tetrahydrooxymorphindole, and a related 4,5-epoxyphenylpyrrolomorphinan.
    Srivastava SK; Shefali S; Miller CN; Aceto MD; Traynor JR; Lewis JW; Husbands SM
    J Med Chem; 2004 Dec; 47(26):6645-8. PubMed ID: 15588100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities.
    Schmidhammer H; Erli F; Guerrieri E; Spetea M
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33147885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel κ-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation.
    Zhang LS; Wang J; Chen JC; Tao YM; Wang YH; Xu XJ; Chen J; Xu YG; Xi T; Hu XW; Wang YJ; Liu JG
    Acta Pharmacol Sin; 2015 May; 36(5):565-71. PubMed ID: 25816912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of linker substitution on the binding of butorphan univalent and bivalent ligands to opioid receptors.
    Fulton BS; Knapp BL; Bidlack JM; Neumeyer JL
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1507-9. PubMed ID: 20144870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cinnamoyl derivatives of 7alpha-aminomethyl-6,14-endo-ethanotetrahydrothebaine and 7alpha-aminomethyl-6,14-endo-ethanotetrahydrooripavine and related opioid ligands.
    Rennison D; Neal AP; Cami-Kobeci G; Aceto MD; Martinez-Bermejo F; Lewis JW; Husbands SM
    J Med Chem; 2007 Oct; 50(21):5176-82. PubMed ID: 17887741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pharmacological Heterogeneity of Nepenthone Analogs in Conferring Highly Selective and Potent κ-Opioid Agonistic Activities.
    Li W; Long JD; Qian YY; Long Y; Xu XJ; Wang YJ; Shen Q; Wang ZN; Yang XC; Xiao L; Sun HP; Xu YL; Chen YY; Xie Q; Wang YH; Shao LM; Liu JG; Qiu ZB; Fu W
    ACS Chem Neurosci; 2017 Apr; 8(4):766-776. PubMed ID: 28033462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands.
    Spetea M; Schmidhammer H
    Handb Exp Pharmacol; 2022; 271():163-195. PubMed ID: 33454858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Peripheral κ-Opioid Receptor Agonists as Novel Analgesics.
    Suzuki S; Sugawara Y; Inada H; Tsuji R; Inoue A; Tanimura R; Shimozono R; Konno M; Ohyama T; Higashi E; Sakai C; Kawai K
    Chem Pharm Bull (Tokyo); 2017; 65(11):1085-1088. PubMed ID: 29093296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel tetrahydroisoquinoline quaternary derivatives as peripheral κ-opioid receptor agonists.
    Guo T; Gan Z; Chen J; Wang D; He L; Song Q; Xu Y
    Bioorg Med Chem; 2016 Jul; 24(13):2964-2970. PubMed ID: 27185012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.